Application of placebo acupuncture in randomized controlled trials in the past 10 years in foreign countries.
- Author:
Lu JU
;
Xiaoliang WU
;
Dake XU
;
Lixia PEI
;
Houxu NING
;
Jianhua SUN
- Publication Type:Journal Article
- MeSH:
Acupuncture Therapy;
instrumentation;
methods;
standards;
Humans;
Internationality;
Needles;
Placebo Effect;
Randomized Controlled Trials as Topic;
standards
- From:
Chinese Acupuncture & Moxibustion
2016;36(2):203-206
- CountryChina
- Language:Chinese
-
Abstract:
The application of placebo acupuncture in randomized controlled trials in the past 10 years (2004-2014) in foreign countries was systematically reviewed to summarize the design of placebo acupuncture; according to category of diseases, advantages and disadvantages were analyzed to explore an ideal placebo acupuncture set. By retrieval in PubMed, EMBASE and OVID databases, the clinical study literature which met the inclusion criteria was searched, and the category of diseases, design of placebo acupuncture and clinical efficacy were analyzed. Totally 29 articles were included. The pain was the leading disease in category of diseases; the most commonly used application of placebo acupuncture design was telescopiform sliding blunt needle, accounting for 45. 16%; the treatment locations were non-acupoints mostly; in the needling depth, approximately 60. 00% selected non-penetrating needling and 26. 67% selected superficial needling; 28 articles indicated that acupuncture and placebo acupuncture had clinical effects, accounting for 96. 55%; 37. 93% of articles indicated acupuncture was superior to placebo acupuncture and 37. 93% of articles indicated acupuncture was not superior to placebo acupuncture. It is concluded that the design of placebo acupuncture should consider multiple factors, including main symptoms, operability, security, blinding and specific effects, and the objective indices should be selected for outcome evaluation.
